Senior Medical Director of Early Phase Oncology @ Eli Lilly and Company
Mythili Koneru's Education
Memorial Sloan-Kettering Cancer Center
Medical Oncology Fellowship
2011 - 2015
Montefiore Medical Center
Internal Medicine Residency Program
2008 - 2011
The University of Chicago
B.A (Cellular and Molecular Biology)
1995 - 1998
New York University
Ph.D (Biomedical Sciences, General)
Robert Wood Johnson Medical School
M.D
Mythili Koneru's Skills
Research
Molecular Biology
Cell Biology
Cell Culture
Immunology
PCR
Biochemistry
Clinical Research
Pharmaceutical Industry
Cancer
Mythili Koneru's Summary
Mythili Koneru, based in Houston, Texas, United States, is currently a Chief Medical Officer at Marker Therapeutics, Inc., bringing experience from previous roles at Marker Therapeutics, Inc. and Eli Lilly and Company. Mythili Koneru holds a 2011 - 2015 Medical Oncology Fellowship @ Memorial Sloan-Kettering Cancer Center. With a robust skill set that includes Research, Molecular Biology, Cell Biology, Cell Culture, Immunology and more, Mythili Koneru contributes valuable insights to the industry. Mythili Koneru has 3 emails on RocketReach.